hexamethonium has been researched along with Ileal Diseases in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Ileal Diseases: Pathological development in the ILEUM including the ILEOCECAL VALVE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, N | 1 |
| Orr-Urtreger, A | 1 |
| Chapman, J | 1 |
| Rabinowitz, R | 1 |
| Korczyn, AD | 1 |
1 other study available for hexamethonium and Ileal Diseases
| Article | Year |
|---|---|
Deficiency of nicotinic acetylcholine receptor beta 4 subunit causes autonomic cardiac and intestinal dysfunction.
Topics: Acetylcholine; Animals; Aortic Bodies; Disease Models, Animal; Ganglia, Autonomic; Ganglionic Blocke | 2003 |